File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: The crucial regulatory role of type I interferon in inflammatory diseases

TitleThe crucial regulatory role of type I interferon in inflammatory diseases
Authors
Issue Date21-Dec-2023
PublisherBioMed Central
Citation
Cell & Bioscience, 2023, v. 13 How to Cite?
Abstract

Type I interferon (IFN-I) plays crucial roles in the regulation of inflammation and it is associated with various inflammatory diseases including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and periodontitis, impactingpeople’s health and quality of life. It is well-established that IFN-Is affect immune responses and inflammatory factors by regulating some signaling. However, currently, there is no comprehensive overview of the crucial regulatory role of IFN-I in distinctive pathways as well as associated inflammatory diseases. This review aims to provide a narrative of the involvement of IFN-I in different signaling pathways, mainly mediating the related key factors with specific targets in the pathways and signaling cascades to influence the progression of inflammatory diseases. As such, we suggested that IFN-Is induce inflammatory regulation through the stimulation of certain factors in signaling pathways, which displays possible efficient treatment methods and provides a reference for the precise control of inflammatory diseases.


Persistent Identifierhttp://hdl.handle.net/10722/339361
ISSN
2023 Impact Factor: 6.1
2023 SCImago Journal Rankings: 1.836

 

DC FieldValueLanguage
dc.contributor.authorJi, Ling-
dc.contributor.authorLi, Tianle-
dc.contributor.authorChen, Huimin-
dc.contributor.authorYang, Yanqi-
dc.contributor.authorLu, Eryi-
dc.contributor.authorLiu, Jieying-
dc.contributor.authorQiao, Wei-
dc.contributor.authorChen, Hui-
dc.date.accessioned2024-03-11T10:35:59Z-
dc.date.available2024-03-11T10:35:59Z-
dc.date.issued2023-12-21-
dc.identifier.citationCell & Bioscience, 2023, v. 13-
dc.identifier.issn2045-3701-
dc.identifier.urihttp://hdl.handle.net/10722/339361-
dc.description.abstract<p>Type I interferon (IFN-I) plays crucial roles in the regulation of inflammation and it is associated with various inflammatory diseases including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and periodontitis, impactingpeople’s health and quality of life. It is well-established that IFN-Is affect immune responses and inflammatory factors by regulating some signaling. However, currently, there is no comprehensive overview of the crucial regulatory role of IFN-I in distinctive pathways as well as associated inflammatory diseases. This review aims to provide a narrative of the involvement of IFN-I in different signaling pathways, mainly mediating the related key factors with specific targets in the pathways and signaling cascades to influence the progression of inflammatory diseases. As such, we suggested that IFN-Is induce inflammatory regulation through the stimulation of certain factors in signaling pathways, which displays possible efficient treatment methods and provides a reference for the precise control of inflammatory diseases.</p>-
dc.languageeng-
dc.publisherBioMed Central-
dc.relation.ispartofCell & Bioscience-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleThe crucial regulatory role of type I interferon in inflammatory diseases-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1186/s13578-023-01188-z-
dc.identifier.volume13-
dc.identifier.eissn2045-3701-
dc.identifier.issnl2045-3701-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats